A world without antibiotics? The risk is real, experts say

January 19, 2014 by Mariette Le Roux

Humans face the very real risk of a future without antibiotics, a world of plummeting life expectancy where people die from diseases easily treatable today, scientists say.

Experts tracking the rise of say years of health gains could be rolled back by mutating microbes that make illnesses more difficult and expensive to cure and carry a higher risk of death.

Some say the threat to wellbeing is on the scale of global warming or terrorism—yet resistance is being allowed to spread through an entirely preventable means— improper use of antibiotics.

"It is a major public health problem," Patrice Courvalin, who heads the Antibacterial Agents Unit of France's Pasteur Institute, told AFP.

"It is about more than not being able to treat a disease. It will erase much progress made in the last 20-30 years."

Without antibiotics to tackle opportunistic bacteria that pose a particular risk for people who are very ill, major surgery, organ transplants or cancer and leukaemia treatment may become impossible, he explained.

"In some parts of the world, already we have run out of antibiotics," said Timothy Walsh, a professor of medical microbiology at Cardiff University.

"In places in India, Pakistan, Bangladesh, possibly Russia, Southeast Asia, central South America, we are at the end game. There's nothing left. And unfortunately there is nothing in the pipeline either."

Resistance to drugs emerges through changes in the bacterium's genetic code—altering the target on its surface to which antibiotics would normally bind, making the germ impenetrable or allowing it to destroy or "spit out" the antibiotic.

These super-germs triumph through Darwinian pressure, helped by humans.

The wrong antibiotics, taken for too short a period, in too low a dose or stopped to early, will fail to kill the altered microbes.

Instead, the drugs will indiscriminately damage other bacteria and give the resistant strain a competitive advantage—allowing it to dominate and spread.

At the base of the problem is doctors prescribing antibiotics wrongly or unnecessarily, and the ease with which medicines can be obtained without a script in some parts of the world, including Asia and Africa.

As much as 70 percent of antibiotics are given for viral infections, against which they are wholly ineffective, the experts say.

Then there is the problem of farmers in countries like the United States adding antibiotics to animal feed to help herds grow faster.

Compounding all of this is the rise in global travel—a boon for bacterial spread, and a sharp drop in antibiotics development blamed on a lack of financial incentives for the pharmaceutical industry.

A return to the pre-antibiotic era?

The World Health Organisation (WHO) says drug resistance "threatens a return to the pre-antibiotic era".

"Many infectious diseases risk becoming untreatable or uncontrollable," it states in a factsheet on antimicrobial resistance.

A case in point: some 450 000 people developed multi-drug resistant (MDR) TB in 2012 and 170,000 died from it. MDR TB does not respond to the most potent TB drugs—isoniazid and rifampin.

Nearly 10 percent of MDR cases are thought to be of the even deadlier XDR (extensively drug resistant) variety which does not respond to a yet wider range of drugs.

Like other drug-resistant microbes, MDR and XDR TB can be transferred directly between people—you can get it even if you have never taken antibiotics in your life.

"Antibiotic resistance is an emerging disease and a societal problem. The use you can make of an antibiotic depends on the use made by others," said Courvalin.

Another worry for health planners today is the spread of a multi-drug resistant strain of the bacterium Klebsiella pneumoniae—a common cause of infections of the urinary tract, respiratory tract and bloodstream, and a frequent source of hospital outbreaks.

In some parts of the world, only the carbapenem antibiotics class remains effective, but now signs are emerging of resistance even to this last line of defence.

Antibiotics are thought to have saved hundreds of millions of lives since Alexander Fleming first discovered penicillin in 1928.

But even Fleming's own warnings of impending drug resistance went unheeded, and now scientists say people may start dying from infections like meningitis and septicaemia that are eminently curable today.

"If we keep going like this, the vast majority of human bacterial pathogens will be multi-resistant to antibiotics," said Courvalin.

The answer? Prudent drug use—better and faster diagnosis to determine whether an infection is viral or bacterial and whether it is even susceptible to treatment.

Farmers must stop feeding to their livestock, and hospital and individuals improve their hygiene to prevent bacterial spread.

Yet few experts believe the damage can be undone.

"The bugs have become very sophisticated, they've become very complex," said Walsh.

"You can decrease resistance or reduce it, but never completely reverse it."

Explore further: CDC addresses burden, threat of antibiotic resistance

Related Stories

CDC addresses burden, threat of antibiotic resistance

January 6, 2014
(HealthDay)—The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

Evolution winning in bacteria vs antibiotics arms race

November 19, 2013
Science is running out of new ways to attack harmful bacteria, while drug companies are abandoning antibiotic research and development, according to a University of Adelaide drug expert.

Antibiotics – friend and foe?

November 18, 2013
European Antibiotic Awareness Day is marked on the 18th November every year. This year in Norway, a seminar for health care providers about antibiotic use and resistance will be held, as well as several local events around ...

3Qs: The effect of antibiotic resistant bacteria

October 2, 2013
Last month, the Centers for Disease Control and Prevention released a report titled Antibiotic resistance threats in the United States, 2013, that served as a first-ever snapshot of the effect antibiotic resistant microbes ...

Probe highlights risk from South Africa's drug-resistant TB

January 17, 2014
A long-term probe has found that South Africans with highly drug-resistant TB are "systematically" discharged from hospital without being cured, placing themselves and others at risk, its authors said Friday.

Recommended for you

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

Opioids overused in migraine treatment, regardless of race, study finds

August 17, 2017
African-Americans are more likely to experience debilitating migraine headaches than whites, but a new study probing the issue found no evidence of racial disparities in treatment practices.

Finding better ways to reduce serious drug side effects

August 14, 2017
Many of the medicines we depend on to treat disease—and even to save our lives—pose potentially serious risks along with their benefits. Data from the U.S. Centers for Disease Control and Prevention indicate that about ...

Ultrasound-triggered liposomes for on-demand, local anesthesia

August 10, 2017
Researchers at Boston Children's Hospital have found a new way to non-invasively relieve pain at local sites in the body; such systems could one day improve pain management by replacing addictive opioids and short-lasting ...

Independent pharmacies and online coupons help patients save money on drugs

August 8, 2017
Uninsured patients or those with limited prescription drug coverage can save significant money by buying their drugs at independent pharmacies instead of big box, grocery or chain drug stores and by using discount coupons, ...

New study generates more accurate estimates of state opioid and heroin fatalities

August 7, 2017
Although opioid and heroin deaths have been rising dramatically in the U.S., the magnitude of the epidemic varies from state to state, as does the relative proportion of opioid vs heroin poisonings. Further complicating the ...


Adjust slider to filter visible comments by rank

Display comments: newest first

Jan 20, 2014
This comment has been removed by a moderator.
not rated yet Jan 20, 2014
Antibiotics are used in many health concerns and of course, without the antibiotics risk is common. These antibiotics are the most effective treatment for preventing any infection, whether it is skin infection, viral infection or bacterial infection, only antibiotics are provided. I am glad that I came across to your post and read this brilliant information. Thanks for the share and keep awaiting for more new posts.
not rated yet Jan 20, 2014
Can anti-biotic resistant bugs be prevented in a capitalist determined resource allocation society? There's a communal harm/benefit cost part of antibiotic resistance that is not recognized or accounted for in our free market structure. Basically as long as people make antibiotics or use them in a private property based marketplace, then communal "externalities" are irrelevant in the risk reward calculations of individuals choosing their daily actions.
Basically it doesn't cost the doctors or medical professionals individually so they don't spend resources on preventing antibiotic resistance. This happens at a individual level and business level so the problem of antibacterial resistance simply does not factor into our ROI calculations. At a society and civilization scale we do care as a group, but that doesn't result in changes to activities of individuals for reasons tied to our economic policy decisions.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.